I was asked by one of the attendings to give a presentation on the pharmacology of the drugs to treat CMV because we had 2 patients this week whose CMV seemed to have been reactivated post chemotherapy. For one of the patients, the side effects he experienced with the initial treatment (valganciclovir) got so bad we had to switch him to the second line treatment (foscarnet) which has potentially worse side effects for his kidneys but would not affect his white blood cells as much; we really needed to rebuild his immune system quickly because he was deteriorating rapidly. As of Friday afternoon we had to transfer him to the ICU so I hope he makes it through the weekend.
So I found a very cool feature of blogger that allows me to post my slides so here is my presentation if you're interested:
No comments:
Post a Comment